期刊文献+

急性冠脉综合征39例临床观察 被引量:2

下载PDF
导出
摘要 目的观察急性冠脉综合征(ACS)的发病机制、临床表现及诊治特点。方法选择我院近年来收治的急性冠脉综合征患者39例,对其临床资料进行回顾性总结分析,同时观察治疗前后患者症状、体征及实验室指标变化。结果治疗结束后本组显效27例,有效11例,无效1例,显效率69.2%、总有效率97.4%。治疗14天后心电图疗效:ST段恢复正常或改善37例,ST段无变化或恶化2例;出院后1个月内再发心绞痛l例,未发现再发急性心肌梗死患者。结论掌握急性冠脉综合征的临床特点,采取针对性的综合性治疗措施,能够显著改善急性冠脉综合征患者的预后,治疗效果显著。
作者 陈吉林
出处 《中国现代药物应用》 2010年第17期47-48,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献3

  • 1Gurfinkel EP, Manos EJ, Mejail RI, et al. Low molecularweight heparin versus regular heparin on aspirin in thetreatment of unstable angina and silent ischemia. J AmColl Cardiol, 2005,26: 313.
  • 2Herrmann HC, Molitemo DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with orwithout abciximb in acute myocardial infarction: results from theSPEED ( GUSTO-4 pilot) Trial. JACC ,2000,36 : 1489-1496.
  • 3施仲伟.急性冠脉综合征早期他汀类药物治疗的临床试验[J].中国医药导刊,2002,4(5):383-385. 被引量:8

二级参考文献17

  • 1Kayikcioglu M, Turkoglu C, Kultursay H, et al. The short term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction. Circulation, 1999;100(18, Suppl I):I- 303
  • 2Arntz H - R, Agrawal R, Wunderlich W, et al. Beneficial effects of pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] study). AmJ Cardiol, 2000; 86(12):1293 ~ 1298
  • 3Aronow HD, Topol EJ, Roe M, et al. Effect of lipid - lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet, 2001;357(9262): 1063 ~ 1068
  • 4Cannon CP, McCabe CH, Bentley J, et al. Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: observations from OPUS - TIMI 16. J Am Coil Cardiol, 2001; 37(2, Suppl A): 334A
  • 5Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care (RIKS - HLA) . Early stat. in treatment following acute myocardial infarction and 1 - year survival. JAMA, 2001; 285(4) :430 ~ 436
  • 6McG uireDK, O'sheaJC, DykeCK, etal. Highlights fron the XXⅡI Congress of the European Society of Cardiology: August 26 to 30, 2000. Am Heart J, 2001;141(1): 164~ 172
  • 7Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA, 2001;285(13):1711~1718
  • 8ThackraySDR, WitteKKA, KhandA, etal. Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT,COPERNICUS, MERIT, CIBIS- Ⅱ, BEST, AMIOVIRT, V- MAC, BREAKTHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure. Eur J Heart Fail, 2001 ;3(1): 117 ~ 124
  • 9SacksFM. Lipid - lowering therapy in acute coronary syndromes. JAMA, 2001;285(13): 1758- 1760
  • 10Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). JAMA, 2001; 285(19):2486~2509

共引文献7

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部